Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of HealthTronics, Inc. - HTRN
06 May 2010 - 1:07PM
Business Wire
Levi & Korsinsky is investigating the Board of Directors of
HealthTronics, Inc. (“HealthTronics” or the “Company”) (NasdaqGS:
HTRN) for possible breaches of fiduciary duty and other violations
of state law in connection with their attempt to sell the Company
to Endo Pharmaceuticals Holdings Inc. ("Endo Pharmaceuticals")
(NasdaqGS: ENDP). Under the terms of the transaction, HealthTronics
shareholders will receive $4.85 in cash for each share of
HealthTronics that they own for a total transaction value of
approximately $223 million, including assumption of debt.
The investigation concerns whether the HealthTronics Board of
Directors breached their fiduciary duties to HealthTronics
stockholders by failing to adequately shop the Company before
entering into this transaction and whether Endo Pharmaceuticals is
underpaying for HealthTronics shares, thus unlawfully harming
HealthTronics stockholders. In particular, at least one analysts
set a price target for HealthTronics stock at $7.00 per share.
If you own common stock in HealthTronics and wish to obtain
additional information, please contact Joseph E. Levi, Esq. either
via email at jlevi@zlk.com or by telephone at (212) 363-7500 or
visit http://www.zlk.com/healthtronics-htrn.html.
Levi & Korsinsky has expertise in prosecuting investor
securities litigation and extensive experience in actions involving
financial fraud and represents investors throughout the nation,
concentrating its practice in securities and shareholder
litigation.
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Htetf (MM) (NASDAQ:HTRN)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Htetf (MM) (NASDAQ): 0 recent articles
More Levi & Korsinsky, LLP News Articles